Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex.
暂无分享,去创建一个
[1] A. Engel. Myasthenia gravis and myasthenic syndromes , 1984, Annals of neurology.
[2] A. Cambon-Thomsen,et al. Tumor necrosis factor microsatellites in four European populations. , 1993, Human immunology.
[3] D Elmqvist. Myasthenia Gravis , 1975, The Lancet.
[4] James T. Elder,et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. , 2002, American journal of human genetics.
[5] Y. Yoshikawa,et al. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. , 2003, American journal of human genetics.
[6] Sue Povey,et al. Gene map of the extended human MHC , 2004, Nature Reviews Genetics.
[7] R. Hohlfeld,et al. The role of the thymus in myasthenia gravis. , 1994, Advances in neuroimmunology.
[8] J. McCluskey,et al. Disease Associations with Complotypes, Supratypes and Haplotypes , 1983, Immunological reviews.
[9] E. G. de la Concha,et al. MHC Susceptibility Genes to IgA Deficiency Are Located in Different Regions on Different HLA Haplotypes1 , 2002, The Journal of Immunology.
[10] J. Dausset. The Major Histocompatibility Complex in Man , 1992 .
[11] B. Eymard,et al. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. , 2001, Archives of neurology.
[12] H. Erlich,et al. MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.
[13] Tariq Ahmad,et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. , 2003, Human molecular genetics.
[14] H. Garchon,et al. An interval tightly linked to but distinct from the H2 complex controls both overt diabetes (Idd16) and chronic experimental autoimmune thyroiditis (Ceat1) in nonobese diabetic mice. , 2002, Diabetes.
[15] H. Shin,et al. Association of tumor necrosis factor polymorphisms with asthma and serum total IgE. , 2004, Human molecular genetics.
[16] J. Todd,et al. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and –DRB1 , 2003, Genes and Immunity.
[17] Terence Dwyer,et al. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. , 2002, American journal of human genetics.
[18] H. Inoko,et al. A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. , 2001, Genomics.
[19] J. Patrick,et al. Autoimmune Response to Acetylcholine Receptor , 1973, Science.
[20] F. Christiansen,et al. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes , 1992, Immunogenetics.
[21] D. Drachman. Myasthenia Gravis and the Thyroid Gland , 1962 .
[22] M. Baets,et al. The role of antibodies in myasthenia gravis , 2002, Journal of the Neurological Sciences.
[23] A. Cambon-Thomsen,et al. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[24] H. Garchon,et al. Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients. , 1997, Journal of autoimmunity.
[25] B. Eymard,et al. Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies , 2001, Neurology.
[26] David D. Chaplin,et al. Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal Centers , 1996, Science.
[27] A. Cambon-Thomsen,et al. HLA ‐A,‐B,‐DR HAPLOTYPE FREQUENCIES IN FRANCE—IMPLICATIONS FOR RECRUITMENT OF POTENTIAL BONE MARROW DONORS , 1995, Transplantation.
[28] T. Ogihara,et al. Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus. , 2000, Human immunology.
[29] F. Christiansen,et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases , 1999, Immunological reviews.
[30] Wei Chen,et al. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. , 2002, American journal of human genetics.
[31] B P Koeleman,et al. Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21. , 2000, Human molecular genetics.
[32] James T. Elder,et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. , 2000, American journal of human genetics.
[33] P. Christadoss. C5 gene influences the development of murine myasthenia gravis. , 1988, Journal of immunology.
[34] S. Higgs,et al. Genetic Evidence for Involvement of Classical Complement Pathway in Induction of Experimental Autoimmune Myasthenia Gravis 1 , 2003, The Journal of Immunology.
[35] P. H. Moghaddam,et al. Genetic Structure of IDDM1: Two Separate Regions in the Major Histocompatibility Complex Contribute to Susceptibility or Protection , 1998, Diabetes.
[36] A. Vincent,et al. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. , 1980, Brain : a journal of neurology.
[37] F. Breedveld,et al. The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. , 2001, Human immunology.
[38] C. Caruso,et al. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. , 2002, Autoimmunity reviews.
[39] G. Kollias,et al. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.
[40] E. Thorsby,et al. Invited anniversary review: HLA associated diseases. , 1997, Human immunology.
[41] A. Katz,et al. Genetic prediction of nonresponse to hepatitis B vaccine. , 1989, The New England journal of medicine.
[42] F. Dudbridge. Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.
[43] F. Naeim,et al. Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis. , 1978, Tissue antigens.
[44] C. Alper. GENETIC PREDICTION OF NON-RESPONSE TO HEPATITIS B VACCINE , 1990 .
[45] I. Tsiropoulos,et al. Associated autoimmune diseases in myasthenia gravis A population‐based study , 1995, Acta neurologica Scandinavica.
[46] B. Eymard,et al. Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci , 2004, Genes and Immunity.
[47] J. Lindstrom,et al. Antibody to acetylcholine receptor in myasthenia gravis , 1976, Neurology.
[48] J. Dausset,et al. Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Bunce,et al. A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C. , 1999, Human immunology.
[50] S. Horowitz,et al. HL-A ANTIGENS IN MYASTHENIA GRAVIS , 1974 .
[51] The Chinese Human Genome Sequencing Consortium,et al. Complete sequence and gene map of a human major histocompatibility complex , 1999 .
[52] Gen Tamiya,et al. Complete sequence and gene map of a human major histocompatibility complex , 1999 .
[53] A. Salmaggi,et al. Tumour necrosis factor microsatellite alleles in an Italian population. , 1997, European journal of immunogenetics.
[54] J. Dausset,et al. Genetics of HLA disease association. , 1981, Annual review of genetics.
[55] F. Schuit,et al. Genetic structure of IDDM1: two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Belgian Diabetes Registry. , 1998, Diabetes.